About
Board of Directors
Norbert G. Riedel, PhD
Chairman of the BoardChairperson, Eton Pharmaceuticals, Inc.,Director, Jazz Pharmaceuticals
PJ Anand
Founder, President and Chief Executive Officer
Founder, Former CEO Alcyone Therapeutics (Acquired by Biogen)
Founder, Former CEO Alcyone Therapeutics (Acquired by Biogen)
Jill M. Weimer, PhD
Chief Science Officer, Amicus TherapeuticsSenior Director of Therapeutic Development and Scientist, Sanford Research
Professor, Department of Pediatrics at the University of South Dakota
Professor, Department of Pediatrics at the University of South Dakota
David Donabedian, PhD, MBA
Founding CEO, Newleos Therapeutics,
Executive Partner, Longwood Venture Fund
Executive Partner, Longwood Venture Fund
Richard Upton
Partner, Harbor Light Capital Partners
Edgar D. Jannotta, Jr
Board ObserverFormer Managing Principle and Co-Manager of Healthcare Group,
GTCR Golder Rauner, LLC
GTCR Golder Rauner, LLC
Dennis Durbin, MD, MSCE
Board ObserverProfessor and Vice-Chair for Research, Department of Pediatrics, The Ohio State University College of MedicinePresident, Abigail Wexner Research Institute, Nationwide Children’s Hospital